Literature DB >> 29807037

Hair and salivary cortisol in a cohort of women with chronic fatigue syndrome.

Megan E Roerink1, Sean H P P Roerink2, Nadine Skoluda3, Marieke E van der Schaaf4, Ad R M M Hermus2, Jos W M van der Meer2, Hans Knoop5, Urs M Nater3.   

Abstract

Hypocortisolism has been found in CFS patients in blood, urine, and saliva. It is unclear if hypocortisolism can also be demonstrated using long-term cortisol measurements, such as cortisol in hair. In addition, the interaction between the HPA axis and the immune system, both expected to play an important role in CFS, is unclear. The objective of the current study was to compare hair and salivary cortisol concentrations in a cohort of female CFS patients to those in healthy controls, and to test the effect of an interleukin-1 receptor antagonist (anakinra) on the HPA axis. Salivary cortisol concentrations of 107 CFS patients were compared to 59 healthy controls, with CFS patients showing a decreased cortisol awakening response (4.2 nmol/L ± 5.4 vs 6.1 nmol/L ± 6.3, p = 0.036). Total cortisol output during the day did not differ significantly in saliva, but there was a trend to lower hair cortisol in a subset of 46 patients compared to 46 controls (3.8 pg/mg ± 2.1 vs 4.3 pg/mg ± 1.8, p = 0.062). After four weeks of treatment with either daily anakinra (100 mg/day) or placebo, there was a slight decrease of hair cortisol concentrations in the anakinra group compared to an increase in the placebo group (p = 0.022). This study confirms the altered dynamics of the HPA axis in a group of CFS patients, and for the first time shows that this might also be present for long-term cortisol measures.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic fatigue syndrome; Hair cortisol; Salivary cortisol

Mesh:

Substances:

Year:  2018        PMID: 29807037     DOI: 10.1016/j.yhbeh.2018.05.016

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  5 in total

Review 1.  Pain and Cortisol in Patients with Fibromyalgia: Systematic Review and Meta-Analysis.

Authors:  Edurne Úbeda-D'Ocasar; Victor Jiménez Díaz-Benito; Gracia María Gallego-Sendarrubias; Juan Antonio Valera-Calero; Ángel Vicario-Merino; Juan Pablo Hervás-Pérez
Journal:  Diagnostics (Basel)       Date:  2020-11-09

2.  Are there subgroups of chronic fatigue syndrome? An exploratory cluster analysis of biological markers.

Authors:  Tarjei Tørre Asprusten; Line Sletner; Vegard Bruun Bratholm Wyller
Journal:  J Transl Med       Date:  2021-01-30       Impact factor: 5.531

3.  The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?

Authors:  Iñigo Murga; Larraitz Aranburu; Pascual A Gargiulo; Juan-Carlos Gómez-Esteban; José-Vicente Lafuente
Journal:  J Transl Med       Date:  2021-12-04       Impact factor: 8.440

4.  No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [11C]-PK11195.

Authors:  Ruud Raijmakers; Megan Roerink; Stephan Keijmel; Leo Joosten; Mihai Netea; Jos van der Meer; Hans Knoop; Hans Klein; Chantal Bleeker-Rovers; Janine Doorduin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-11-23

5.  Salivary Biomarker Profiles and Chronic Fatigue among Nurses Working Rotation Shifts: An Exploratory Pilot Study.

Authors:  Shinya Yamaguchi; Kazuhiro Watanabe; Naotaka Sugimura; Inaho Shishido; Issei Konya; Tomoko Fujita; Yuichi Yoshimitsu; Shintaro Kato; Yoichi M Ito; Rika Yano
Journal:  Healthcare (Basel)       Date:  2022-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.